The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse - Hartkopf, A D; Banys, M; Meier-Stiegen, F (Breast Cancer Res Treat, 2013)